title: Two cases of myelofibrosis with severe thrombocytopenia and symptomatology successfully treated with combination of pomalidomide and ruxolitinib.
authors.affiliation: Division of Hematology/Oncology, Brookdale Hospital Medical Center , Brooklyn, New York, NY , USA.
authors.forename: Mirela
authors.initials: M
authors.lastname: Andrei
authors.forename: Hemant
authors.initials: H
authors.lastname: Sindhu
authors.forename: Jen Chin
authors.initials: JC
authors.lastname: Wang
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D005221:Fatigue / Q000150:complications / Q000517:prevention & control*; D006801:Humans; D007958:Leukocyte Count; D008297:Male; D009570:Nitriles; D010976:Platelet Count; D055728:Primary Myelofibrosis / Q000150:complications / Q000188:drug therapy* / Q000473:pathology; D011720:Pyrazoles / Q000008:administration & dosage; D011743:Pyrimidines; D011788:Quality of Life; D013792:Thalidomide / Q000008:administration & dosage / Q000031:analogs & derivatives; D013921:Thrombocytopenia / Q000150:complications / Q000517:prevention & control*; D016896:Treatment Outcome
chemical_list: D009570:Nitriles; D011720:Pyrazoles; D011743:Pyrimidines; D013792:Thalidomide; C540383:ruxolitinib; C467566:pomalidomide